Peptide Knowledge Base · Recovery
KPV: what it is, what the evidence says, and its real status
Short version
A small peptide people ask about for gut and inflammatory support.
Education onlyEvidence grade D · Animal and lab evidence; human trials still to come
That’s the honest answer. Everything below is the detail.
An α-MSH fragment people ask about for gut and inflammation, often alongside BPC-157.
Can you actually get it?
Plain-English verdict: Education only.
Regulatory status: PCAC recommended · rulemaking pending.
How does KPV work?
A tripeptide fragment of α-MSH proposed to modulate inflammatory signaling.
What it does — and what it does not do
What it does: Studied for gut and inflammatory support, often discussed with BPC-157.
What it does not do: It is not a treatment for any diagnosed gut condition.
How honest is the evidence?
Evidence grade D — Animal and lab evidence; human trials still to come.
A grade measures how much human evidence exists, not whether a molecule is good, safe, or worth your interest. Read our grading methodology for what each grade means.
What we still don't know: Human evidence is sparse; effect on specific conditions is unproven.
WADA status: Not prohibited.
How it is taken
No established human clinical dosing; research-stage.
Who should not take it
Not characterized in humans; not a substitute for diagnosis or care of any gut condition.
Sources
α-MSH / KPV anti-inflammatory preclinical literature · FDA PCAC docket, Jul 2026
Compounded medications are not FDA-approved. We keep two signals separate and never collapse them: whether you can get something, and what the rule currently says. See the live FDA Peptide Tracker for status.
Embed this card on your site · free, CC BY 4.0, no key.
Last reviewed · Peptós.LIFE · Not medical advice.
Cite this page
KPV. Peptós.LIFE Peptide Knowledge Base. Reviewed Jun 16, 2026. https://peptos.life/peptides/kpv
Free to reuse under CC BY 4.0, with attribution and a link. Machine-readable: JSON · CSV · what is in the export.